INTEGRATIVE ANALYSIS OF MICROBIAL, GENOMIC, AND BIOCHEMICAL BIOMARKERS FOR EARLY DETECTION AND FORENSIC CHARACTERIZATION OF CHRONIC INFLAMMATORY JOINT AND SPINE DISORDERS

Abstract

The aetiologies of chronic inflammatory joint and spine disorders are complex, involving interaction between immune dysregulation, imbalance in microbiomes, genetic susceptibility, epigenetic regulation, biochemical disruption and tissue degeneration. This comprehensive review synthesizes current evidence on microbial, genomic, and biochemical biomarkers for early detection, disease stratification, and forensic characterization of these disorders. Microbial biomarkers, including gut dysbiosis, bacterial DNA, and bacterial–fungal networks, provide insight into host–microbiome interactions and their contribution to systemic inflammation. Genomic and epigenetic biomarkers clarify inherited risk, immune regulation, cellular heterogeneity, and disease susceptibility. Biochemical biomarkers, including cytokines, chemokines, proteomic signatures, metabolites, and synovial fluid markers, reflect active inflammation, tissue injury, and therapeutic response. The review further highlights the value of multi-omics integration, artificial intelligence, network biology, imaging biomarkers, and clinical data systems in developing more precise diagnostic and prognostic models. Forensic applications are also considered, particularly the use of integrated molecular signatures for biological profiling, disease reconstruction, and pathological characterization. Although a wide range of clinical applications have been proposed, their implementation is limited by the need for validation of these biomarkers, heterogeneity of data, ethical issues, and the requirement for standardizing analytical workflows. Precise diagnostics and forensic interpretation in chronic inflammatory joint and spine diseases may be feasible by integrated biomarker strategies.